Brexanolone
RxNorm 2121777
Concept Hierarchy & Relationship Mapping
RxNorm Concept Unique Identifier (RxCUI) 2121777 represents a standardized clinical drug concept used for cross-system interoperability. This concept aggregates multiple Atom IDs (AUIs), which are specific naming variations and synonyms used across pharmaceutical databases to ensure accurate medication mapping for: brexanolone.
The following semantic concepts and normalized strings are associated with this clinical entity:
This clinical crossover tool is designed for healthcare professionals, pharmacists, and data analysts to safely compare substitute products and manage medication interoperability.
INPrescribable
Ingredient (IN):
Brexanolone
(Atom ID: 10894518)
PTPrescribable
Designated preferred name (PT):
Brexanolone
(Atom ID: 11435540)
FNPrescribable
Full form of descriptor (FN):
Brexanolone (substance)
(Atom ID: 11435541)
PTPrescribable
Designated preferred name (PT):
Brexanolone-containing product
(Atom ID: 11435544)
FNPrescribable
Full form of descriptor (FN):
Product containing brexanolone (medicinal product)
(Atom ID: 11438276)
Patient Education
Brexanolone Injection
Brexanolone injection is used for the treatment of postpartum depression (PPD) in adults. Brexanolone injection is in a class of medications called neurosteroid antidepressants. It works by changing the activity of certain natural substances in the brain.
[Learn More]
* Please review the disclaimer below.